Integrin beta 1 and mannose receptor 2 are involved in the antifungal activity of bronchial epithelial cells through Aspergillus fumigatus lectin FleA interactions

This study identifies that bronchial epithelial cells utilize the fungal lectin FleA to engage host receptors integrin beta 1 and mannose receptor 2, facilitating spore internalization and inhibiting the germination of *Aspergillus fumigatus* into invasive hyphae.

The Gist

The Big Picture: A Battle in the Lungs

Imagine your lungs are a bustling city, and the bronchial epithelial cells (BECs) are the city guards standing on the front line. Every day, invisible "invaders" called Aspergillus fumigatus spores float in the air and try to sneak in.

Usually, these spores are harmless. But if they land in a person with a weak immune system, they can wake up, grow long tentacles (called hyphae), and start destroying the city walls. This disease is called aspergillosis.

This paper discovers how the city guards fight back to stop the invaders before they can grow. They found that the guards use two different weapons to win the battle.

---

Weapon #1: The Sticky Trap (Laminin-332)

The Analogy:
Imagine the city guards realize the invaders are trying to climb over the wall. To stop them, the guards quickly spray a super-strong, sticky glue all over the wall. This glue is a protein called Laminin-332.

What the paper says:
When the fungus tries to land, the lung cells activate a specific alarm system (called the PI3K pathway). This alarm tells the cells to produce more of this "sticky glue."

• The Result: The fungus gets stuck to the wall. It can't move, it can't grow its tentacles, and it eventually dies.
• The Catch: If you block the alarm system (using a drug called LY294002), the guards don't make the glue. The fungus slips right past, grows its tentacles, and causes damage.

---

Weapon #2: The ID Check and the Trash Can (FleA, ITGB1, and MRC2)

The Analogy:
The fungus isn't just a blob; it wears a specific "uniform" or badge called FleA. This badge is a key that the fungus uses to try and unlock the city gates.

The guards have a special security team that recognizes this specific badge.

1. The ID Scanners (ITGB1 and MRC2): These are proteins on the surface of the lung cells. They act like security scanners that spot the fungus's "FleA badge."
2. The Grab-and-Throw (Endocytosis): Once the scanners spot the badge, they grab the fungus and pull it inside the cell.
3. The Trash Can (LAMP1): Once inside, the fungus is dumped into a cellular "trash can" (a lysosome). This is a place where bad things are broken down and destroyed.

What the paper says:
The researchers found that the fungus's FleA protein binds directly to two specific guards on the cell surface: ITGB1 and MRC2.

• The Process: The fungus lands, the guards (ITGB1/MRC2) grab it, and they haul it inside the cell.
• The Journey: Inside the cell, the fungus is passed to the "trash can" (LAMP1).
• The Outcome: By trapping the fungus inside the cell and sending it to the trash, the guards prevent it from growing its dangerous tentacles outside.

The "Aha!" Moment:
The researchers proved this by turning off the "scanners" (ITGB1 and MRC2) using a special tool (siRNA). When the scanners were turned off, the fungus wasn't grabbed. It stayed outside, grew its tentacles, and the city (the lung) got damaged.

---

The Two-Step Defense Strategy

The paper concludes that the lung cells use a two-step defense plan:

1. Step 1 (The Glue): Use the PI3K alarm to make Laminin-332 (the glue) to stick the fungus to the wall so it can't run away.
2. Step 2 (The Capture): Use the FleA badge to trigger ITGB1 and MRC2 (the scanners) to grab the fungus and throw it in the LAMP1 trash can.

Why Does This Matter?

The "So What?"
Currently, we have very few drugs to treat fungal infections, and the fungus is becoming resistant to them. This research gives us a new idea for a cure.

Instead of trying to kill the fungus with poison (which hurts the patient and the fungus fights back), we could design a fake badge.

• Imagine giving the fungus a fake ID card that looks exactly like its "FleA" badge but doesn't work.
• The fungus would try to use this fake badge to trick the guards, but it would get stuck or confused.
• Or, we could make a drug that blocks the "scanners" (ITGB1/MRC2) so the fungus can't get inside the cell to start its attack.

In short: This paper teaches us exactly how our lungs naturally fight off a dangerous fungus. By understanding the "lock and key" mechanism, scientists can build better tools to help our lungs win the battle in the future.

Technical Summary

1. Problem Statement

Aspergillus fumigatus is a critical fungal pathogen causing severe pulmonary infections (aspergillosis), particularly in immunocompromised individuals. Treatment is hindered by a limited arsenal of antifungal drugs and rising resistance. While the innate immune system usually prevents the fungus from transitioning from dormant conidia (spores) to invasive hyphae, the specific molecular mechanisms by which bronchial epithelial cells (BECs) recognize and restrict this transition remain incompletely understood. Previous work established that BECs inhibit fungal germination via a PI3K-dependent pathway involving the fungal fucose-specific lectin FleA, but the host cellular receptors and downstream trafficking mechanisms mediating this interaction were unknown.

2. Methodology

The study employed a multi-omics and functional validation approach using human bronchial epithelial cells (BEAS-2B) and A. fumigatus conidia:

• Transcriptomics: BECs were infected with A. fumigatus with or without the PI3K inhibitor LY294002. RNA-seq was performed at 0, 2, and 4 hours to identify genes regulated by the PI3K pathway during infection.
• Functional Knockdown: siRNA was used to silence candidate genes (LAMB3, LAMC2, ITGB1, MRC2, LAMP1) to assess their impact on fungal filamentation (measured by microscopic scoring and galactomannan release).
• Affinity Co-precipitation & Proteomics: Biotinylated FleA was used to pull down interacting host proteins from BEC lysates. Interactions were identified via LC-MS/MS.
• Biophysical Binding Assays: Surface Plasmon Resonance (SPR) and Biolayer Interferometry (BLI) were used to quantify the binding affinity ($K_D$) between FleA and candidate receptors (ITGB1 and MRC2).
• Spatiotemporal Imaging: Confocal microscopy and Proximity Ligation Assay (PLA) were utilized to visualize the co-localization of FleA with host receptors and track intracellular trafficking over time (15 min to 4 hours).
• Adhesion Assays: Conidial adhesion was quantified by counting colony-forming units (CFUs) after pre-incubation with exogenous laminin or FleA.

3. Key Contributions

The study identifies two distinct, complementary pathways through which BECs exert antifungal activity:

1. A PI3K/Laminin-332 Axis: A mechanism promoting conidial adhesion.
2. A FleA-Dependent Axis: A mechanism involving specific host receptors (ITGB1 and MRC2) that facilitates lectin uptake and intracellular trafficking, preventing fungal germination.

Crucially, the study defines Integrin Beta 1 (ITGB1) and C-type Mannose Receptor 2 (MRC2) as the primary host receptors for the fungal lectin FleA.

4. Detailed Results

A. The PI3K/Laminin-332 Axis (Adhesion)

• Transcriptomics: PI3K inhibition significantly downregulated LAMB3 and LAMC2 (encoding laminin-332) during infection.
• Validation: Silencing LAMB3 and LAMC2 simultaneously increased fungal filamentation and galactomannan release, indicating reduced antifungal activity.
• Adhesion: Exogenous laminin-332 enhanced conidial adhesion to BECs, whereas FleA did not. This suggests laminin-332 is critical for the initial attachment of conidia to the epithelium, a step regulated by PI3K signaling.

B. Identification of FleA Receptors (ITGB1 and MRC2)

• Proteomics: Affinity co-precipitation with biotin-FleA identified ITGB1, MRC2, and LAMP1 as the top host interactors. These proteins mapped to the "phagosome" KEGG pathway.
• Functional Silencing:
  • Silencing ITGB1 or MRC2 individually restored fungal filamentation (increased galactomannan), demonstrating their necessity for antifungal activity.
  • Silencing LAMP1 had no effect on filamentation, suggesting it is not essential for the initial inhibition but may be involved in later trafficking.
  • Combined silencing of ITGB1 and MRC2 did not show an additive effect, implying they function in the same pathway.
• Binding Affinity: SPR and BLI confirmed direct, nanomolar-affinity interactions between FleA and both ITGB1 ($K_D \approx 5.6$ nM) and MRC2 ($K_D \approx 4.8$ nM).

C. Spatiotemporal Dynamics and Trafficking

• Kinetics:
  • ITGB1: Showed transient co-localization with FleA at the plasma membrane and cytoplasm at early time points (15–30 min).
  • MRC2: Displayed sustained co-localization with FleA from 15 min up to 4 hours, forming intracellular aggregates.
  • LAMP1: FleA co-localized with LAMP1-positive compartments at later time points (2–4 hours), indicating trafficking toward lysosomes.
• Protein Interactions (PLA): No proximity was detected between ITGB1-MRC2 or ITGB1-LAMP1. However, MRC2-LAMP1 proximity increased significantly upon FleA stimulation, suggesting MRC2 mediates the transport of FleA to LAMP1-positive lysosomal compartments.

5. Significance and Conclusion

• Mechanistic Insight: The study elucidates a dual-pathway defense mechanism in BECs: (1) PI3K-driven upregulation of laminin-332 to trap conidia via adhesion, and (2) FleA recognition by ITGB1 and MRC2 to internalize and sequester the fungus into lysosomal compartments, thereby blocking germination.
• Therapeutic Potential: By identifying ITGB1 and MRC2 as critical receptors for FleA, the study highlights these interactions as potential targets for anti-adhesive therapies. Developing antagonists that block FleA-receptor binding could prevent the initial steps of A. fumigatus colonization and invasion.
• Paradigm Shift: The findings suggest that the antifungal activity of BECs is not merely a passive barrier but an active, receptor-mediated process involving specific lectin-carbohydrate recognition and intracellular trafficking, distinct from the classical phagocytic killing seen in immune cells.

This work provides a foundational understanding of how epithelial cells actively restrict fungal virulence, offering new avenues for treating invasive aspergillosis.